Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Przylądek Zdrowia

Research site

Poland ul. Kamieńskiego 47, 30-644 Cracow, Poland

  • 1 trial recruiting
  • Pneumococcal immunisation · Lyme disease · Meningitis meningococcal
  • Adults and children

About Specializations

Przylądek Zdrowia in Cracow, Poland specialises in clinical trials of conditions such as Pneumococcal immunisation, Lyme disease, Meningitis meningococcal, Meningococcal infection, and other specialisations. This site conducts important research.

Main research areas of the site

Bacterial Infections and Mycoses

At Przylądek Zdrowia in Kraków, the team investigates meningococcal infection prevention in young children, testing new vaccine candidates and comparing established products. Studies include evaluation of the MenACYW conjugate vaccine versus the licensed Nimenrix regimen.

  • Comparison of antibody responses between two conjugate vaccines for serogroups A, C, W, and Y
  • Safety and reactogenicity evaluation of next‑generation meningococcal vaccines
  • Immune response assessment across multiple vaccine formulations and serogroups

The goal is to ensure effective, safe immunization strategies for infants and toddlers, supporting public health efforts against bacterial meningitis.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Kamieńskiego 4730-644 CracowPoland
Open in maps ↗
Recruiting now
1 trial
Conditions studied
4

More sites in CracowPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Pneumococcal immunisation

Recruiting

Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:PF-07831695
  • Sponsor:Pfizer Inc.

Pneumococcal immunisation

Not yet recruiting

Safety and immune response of PF-07872412 compared with 20-valent pneumococcal conjugate vaccine for pneumococcal disease in healthy children and adolescents

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:PF-07831695
  • Sponsor:Pfizer Inc.

Lyme disease

Not recruiting

Study on the Effectiveness and Safety of the VLA15 Vaccine for Preventing Lyme Disease in Healthy Individuals Aged 5 and Older

Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years · Healthy volunteers
  • Substances:BORRELIA BURGDORFERI, SEROTYPE 1, OUTER SURFACE PROTEIN A FUSED VIA A LINKER TO BORRELIA BURGDORFERI, SEROTYPE 2, OUTER SURFACE PROTEIN A
  • Sponsor:Pfizer Inc.

Meningitis meningococcal

Not recruiting

Study on the Safety and Immune Response of MenABCWY Vaccine and Drug Combination in Healthy Infants with Meningococcal Infections

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000017986
  • Sponsor:GlaxoSmithKline Biologicals

Meningococcal infection

Not recruiting

Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Sanofi Pasteur
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.